Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.77
0.13 (2.30%)
At close: Aug 15, 2025, 3:59 PM
5.77
0.00%
After-hours: Aug 15, 2025, 07:58 PM EDT
Recursion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -171.9M | -202.49M | -178.91M | -95.84M | -97.54M | -91.37M | -93M | -93.02M | -76.73M | -65.33M | -57.49M | -60.45M | -65.56M | -55.98M | -64.93M | -47.43M | -43.4M | -30.72M |
Depreciation & Amortization | 23.85M | 19.33M | 12.95M | 7.2M | 8M | 7.4M | 15.62M | 7.58M | 5.54M | 3.73M | 3.21M | 2.99M | 2.79M | 2.77M | 2.24M | 2.44M | 2.33M | 1.4M |
Stock-Based Compensation | 26.16M | 36.06M | 30.78M | 18.25M | 16.52M | 16.13M | 16.09M | 16.79M | 11.81M | 8.81M | 7.7M | 8.91M | 5.67M | 5.63M | 4.34M | 3.36M | 5.32M | 1.82M |
Other Working Capital | n/a | -14.38M | -2.07M | 47.92M | -9.66M | -36.58M | -4.53M | -6.65M | -7.6M | -24.07M | -1.3M | -8.48M | -8.55M | 121.48M | -452K | -2.5M | -2.5M | -2.5M |
Other Non-Cash Items | 45.47M | 15.14M | 13.69M | -35.55M | 34.19M | 32.8M | 52.54M | 170K | 2.03M | 3.87M | 2.44M | 1.77M | 5.01M | 2.14M | 1.16M | 464K | 2.38M | 101K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -54.06M | 19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 827K | n/a | n/a |
Change in Working Capital | n/a | n/a | 6.05M | 46.72M | -10.26M | -36.45M | -11.27M | -4.46M | -10.12M | -24.4M | -601K | -7.76M | -9.54M | 122.82M | -3.96M | 7.29M | -275K | -3.36M |
Operating Cash Flow | -76.42M | -131.96M | -115.43M | -59.23M | -82.22M | -102.3M | -74.08M | -72.92M | -67.47M | -73.32M | -44.75M | -54.54M | -61.62M | 77.39M | -61.16M | -33.05M | -33.65M | -30.75M |
Capital Expenditures | -3.15M | -1.83M | -1.65M | -1.56M | -4.18M | -6.65M | -2.42M | -827K | -3.97M | -5.34M | -7.98M | -8.56M | -16.48M | -4.34M | -4.46M | -9.71M | -6.21M | -19.42M |
Cash Acquisitions | n/a | n/a | 277.1M | n/a | n/a | n/a | -71K | n/a | 1.92M | n/a | n/a | n/a | n/a | n/a | -184.17M | n/a | n/a | n/a |
Purchase of Investments | -500K | 3.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.97M | -184.17M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 480K | n/a | n/a | n/a | 61.55M | 21.41M | 147.65M | 69.19M | n/a | n/a | n/a |
Other Investing Acitivies | -2.16M | -8.88M | -350K | -3M | -3M | n/a | -350K | 398K | n/a | -165K | -300K | 61.25M | 21.41M | 147.65M | 184.17M | -184.17M | n/a | n/a |
Investing Cash Flow | -5.81M | -7.27M | 275.46M | -4.56M | -4.18M | -6.65M | -2.49M | -347K | -2.05M | -5.34M | -7.98M | 52.98M | 4.94M | 143.3M | -52.24M | -193.87M | -6.21M | -19.42M |
Debt Repayment | n/a | -2.05M | -2.1M | -2.29M | -26K | -26K | -694K | -24K | -24K | -24K | -23K | -23K | -22K | -22K | -21K | -12.74M | -20K | -20K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 99.74M | 40.53M | 1.71M | 1.78M | 1.6M | 3.05M | 3.26M | 3.79M | 3.81M | 1.95M | 3.57M | 2.36M | 2.69M | 2.11M | 3.82M | 1.64M | 463.73M | 2.15M |
Financial Cash Flow | 97.66M | 40.53M | 10.64M | 16.46M | 263.12M | 13.9M | 80.66M | 53.77M | 3.79M | 1.92M | 147.26M | 2.34M | 2.67M | 2.08M | 3.8M | -11.1M | 463.7M | 2.13M |
Net Cash Flow | 24.69M | -93.87M | 167.19M | -40.29M | 176.6M | -95.28M | 5.22M | -19.62M | -65.55M | -76.74M | 94.22M | 780K | -54.02M | 222.78M | -109.61M | -238.02M | 423.84M | -48.04M |
Free Cash Flow | -79.57M | -133.79M | -117.08M | -60.79M | -86.4M | -108.95M | -76.49M | -73.75M | -71.44M | -78.66M | -52.73M | -63.1M | -78.1M | 73.05M | -65.62M | -42.75M | -39.87M | -50.17M |